1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Nixxy, Inc. received a Nasdaq notice on September 1, 2026 that its stock has closed below $1.00 for 30 consecutive business days, and it has 180 calendar days to regain compliance. The company also named director Elsa Sung as Chief Financial Officer and appointed Joe Conlon as audit committee chair, both effective August 31, 2026, which matters to shareholders given the listing deficiency and oversight changes.
Nasdaq notice dated September 1, 2026: closing bid price below $1.00 for 30 consecutive business days; the stock is not immediately delisted
Company has an automatic 180-calendar day grace period to regain compliance, with a possible second 180-day period
Elsa Sung appointed Chief Financial Officer effective August 31, 2026 and resigned as audit committee chair
Joe Conlon appointed to the board and as audit committee chair; Ashissh Raichura resigned from the board on August 31, 2026
Simmons First National Corp said it will close 26 Simmons Bank branches across its six-state footprint, effective December 4, 2026, as part of a broader review of its retail network. The company expects roughly $20 million to $23 million in pre-tax expenses tied to the closures, mostly in the third quarter of 2026, and is part of a wider set of operating initiatives it expects to cost $40 million to $45 million in the same quarter and to add $37 million to $42 million a year to pre-provision net revenue once fully implemented.
26 Simmons Bank branches to close, effective December 4, 2026; about 100 associates affected, with roughly 70% expected to be placed in other roles
Branch closure expenses estimated at $20 million to $23 million pre-tax, including $17 million to $19 million in real estate write-downs and lease termination fees
Broader initiatives expected to cost $40 million to $45 million pre-tax in Q3 2026 and to lift annual PPNR by $37 million to $42 million once fully implemented, though some benefit may be reinvested
eGain reported fiscal 2026 total revenue of $91.1 million, up 3% from $88.4 million, but full-year GAAP net income fell to $8.9 million from $32.3 million, a year that included a roughly $29.0 million tax benefit. Fourth-quarter revenue declined 5%, and the company guided fiscal 2027 total revenue to $84.5 million to $86.0 million and a GAAP net loss of $2.0 million to $3.0 million, which points to lower revenue and a GAAP loss for shareholders in the coming year.
Q4 fiscal 2026 total revenue was $22.2 million, down from $23.2 million in Q4 fiscal 2025; Q4 GAAP net income was $1.3 million, or $0.05 per diluted share, versus $30.9 million a year earlier.
Full-year fiscal 2026 non-GAAP net income was $13.0 million, or $0.47 per diluted share, up from $5.7 million; GAAP net income was $8.9 million, or $0.32 per diluted share.
Fiscal 2027 guidance: total revenue of $84.5 million to $86.0 million and GAAP net loss of $2.0 million to $3.0 million, or $0.08 to $0.11 per share.
During fiscal 2026 the company repurchased about 1,607,000 shares at an average price of $7.16, totaling $11.5 million.
Oxford Industries reported fiscal 2026 second-quarter net sales of $394 million, down from $403 million a year earlier, and GAAP diluted EPS of $3.25, which includes a $2.07 tariff refund impact. Adjusted EPS rose to $1.34 from $1.26, but the company lowered its fiscal 2026 sales and adjusted EPS guidance, citing softness at Lilly Pulitzer and consumer pressure. For shareholders, the guidance cut outweighs the quarter's adjusted profit gain, though the company declared a $0.70 quarterly dividend.
Q2 fiscal 2026 net sales were $394 million versus $403 million, with Lilly Pulitzer down 5.6% and Johnny Was down 8.8%
GAAP diluted EPS was $3.25 versus $1.12; adjusted EPS was $1.34 versus $1.26
Fiscal 2026 adjusted EPS guidance is now $1.60 to $2.00, versus $2.11 in fiscal 2025; net sales guidance is $1.43 billion to $1.47 billion
Board declared a $0.70 quarterly dividend payable October 30, 2026, to holders of record on October 16, 2026
Guidewire reported fourth-quarter and fiscal 2026 results for the year ended July 31, 2026, with fiscal-year revenue up 23% to $1,475.4 million and fourth-quarter GAAP net income down to $31.4 million from $52.0 million. The company also said Chief Accounting Officer David Peterson will retire effective November 4, 2026, and that CFO Jeff Cooper is expected to take over the principal accounting officer duties, subject to board appointment.
Fiscal 2026 GAAP diluted EPS was $1.63, up from $0.81; fourth-quarter GAAP diluted EPS was $0.38, down from $0.60.
Fourth-quarter total revenue was $411.1 million, up 15%; fourth-quarter GAAP net income was hurt by a $24.0 million foreign currency loss.
Outlook for fiscal 2027 total revenue is $1,707 million to $1,727 million.
Peterson's retirement takes effect November 4, 2026; he is not leaving over any disagreement with the company.
Torrid reported second-quarter fiscal 2026 results on September 3, 2026, with net sales down 11.8% to $231.7 million. Net income rose to $5.2 million, or $0.05 per share, helped by an $11.1 million IEEPA tariff refund recorded in cost of goods sold; excluding that refund, Adjusted EBITDA was $12.1 million versus $21.5 million a year earlier. The company raised its full-year fiscal 2026 outlook to reflect the tariff benefit and said the outlook is otherwise unchanged.
Net sales decreased 11.8% to $231.7 million from $262.8 million; comparable sales fell 6.3%.
Net income was $5.2 million, or $0.05 per share, versus $1.6 million, or $0.02 per share, a year earlier.
Adjusted EBITDA was $23.3 million including the $11.1 million tariff benefit, or $12.1 million excluding it, compared with $21.5 million last year.
Full-year fiscal 2026 outlook: net sales $940 million to $960 million and Adjusted EBITDA $76 million to $86 million; third-quarter Adjusted EBITDA is expected at $15 million to $20 million.
Red River Bancshares filed an investor presentation for September 2026 conferences that includes its second-quarter 2026 results as of June 30, 2026. Net income was $11.8 million and diluted EPS was $1.78, both slightly lower than in the first quarter of 2026 but higher than in the second quarter of 2025.
Net income of $11.8 million in 2Q26, versus $12.0 million in 1Q26 and $10.2 million in 2Q25
Diluted EPS of $1.78 in 2Q26, versus $1.81 in 1Q26 and $1.51 in 2Q25; the filing says 1Q26 included about $590,000 of periodic items that added $0.07 to EPS
Net interest margin (FTE) rose 10 basis points to 3.61%, and net interest income was $29.0 million
Quarterly cash dividend of $0.25 per share; total assets were $3.31 billion and deposits were $2.91 billion as of June 30, 2026
AbbVie completed its acquisition of Apogee Therapeutics on September 3, 2026, paying $135.11 per share in cash, or about $10.9 billion in total equity value. AbbVie reaffirmed its 2026 full-year adjusted diluted EPS guidance of $13.87 to $14.07 and its third-quarter guidance of $3.84 to $3.88, but expects the deal to reduce adjusted EPS by $0.14 in 2026 and about $0.46 in 2027, with accretion beginning in 2032.
Apogee shareholders received $135.11 per share in cash, for a total equity value of about $10.9 billion.
Apogee's common stock ceased trading on NASDAQ before market open on September 3, 2026.
2026 full-year adjusted diluted EPS guidance of $13.87 to $14.07 was reaffirmed and includes a $0.14 per share dilutive impact from Apogee.
The acquisition is expected to reduce adjusted diluted EPS by about $0.46 in 2027, with accretion beginning in 2032.
Duluth Holdings reported fiscal second-quarter 2026 results for the period ended August 2, 2026. Net sales fell 7.8% to $121.4 million, while net income rose to $18.4 million from $1.3 million, helped by $16.3 million in tariff refunds, and the company raised its fiscal 2026 Adjusted EBITDA guidance to $38 million to $42 million.
Diluted EPS was $0.50 versus $0.04 a year earlier, including a $0.44 impact from tariff refunds.
Adjusted EBITDA was $27.0 million versus $12.0 million in the prior-year quarter.
Fiscal 2026 net sales guidance of $540 million to $560 million was affirmed; Adjusted EBITDA guidance was raised from $28 million to $32 million.
Inventory fell 15.5% to $125.2 million, and the company ended the quarter with about $96 million of net liquidity and zero drawn on its $70.0 million asset-based lending facility.
Genesco reported second quarter fiscal 2027 results for the three months ended August 1, 2026, with net sales down 3% to $530 million and comparable sales down 1%. GAAP diluted EPS was $0.32 versus a loss of $1.79 a year earlier, helped by $22.5 million in tariff refunds, and the company raised its adjusted EPS outlook to the high end of the $2.00 to $2.40 range, while cutting its comparable sales expectation to flat.
Net sales were $530 million versus $546 million a year earlier; e-commerce comparable sales fell 6% and stores rose 1%.
GAAP diluted EPS was $0.32 versus a loss of $1.79 last year; adjusted EPS loss narrowed to $0.83 from $1.14.
Full-year adjusted EPS outlook raised to the high end of $2.00 to $2.40; comparable sales now expected flat versus prior guidance of up 1% to 2%.
Brady reported fiscal 2026 fourth-quarter sales of $436.9 million, up 10.0%, and full-year sales of $1.66 billion, up 9.8%. GAAP diluted EPS fell to $0.96 in the quarter from $1.04 as acquisition and integration costs rose, while adjusted diluted EPS rose 17.5% to $1.48. The company also guided fiscal 2027 adjusted diluted EPS to $6.25 to $6.75 and raised its annual dividend to $1.00 per share from $0.98.
Q4 sales $436.9 million, up 10.0%; organic growth 8.4%
Q4 GAAP diluted EPS $0.96 vs. $1.04 a year earlier; adjusted diluted EPS $1.48 vs. $1.26
Fiscal 2027 adjusted diluted EPS guidance of $6.25 to $6.75, including about $0.80 accretion from the IPS segment
Annual dividend raised to $1.00 per share from $0.98; $0.25 quarterly payment on October 30, 2026 to holders of record October 9, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.